New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
08:32 EDTOVASOvaScience issued two U.S. patents covering AUGMENT fertility treatment
OvaScience announced the issuance of two United States patents covering its AUGMENT fertility treatment. AUGMENT is based on the company’s egg precursor cell technology and is being developed to improve egg quality and the success of in vitro fertilization. AUGMENT will be available in international IVF clinics this year. The issuance of these two patents builds upon the company’s Composition of Matter patent on EggPCs, and provides further protection for AUGMENT through at least 2032. The newly issued patents broadly cover the AUGMENT process, including: IVF by AUGMENT; preparing an egg for use with assisted reproductive technologies; and increasing the energy-generating capacity of an egg by AUGMENT. OvaScience plans to introduce AUGMENT this year through an international program called ‘ACE’ or AUGMENT Centers of Excellence, which will enable physicians to gain experience using AUGMENT and generate data. The Company expects to establish ACE clinics in at least four international regions and record 40 to 60 AUGMENT cycles in 2014
News For OVAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 31, 2015
12:31 EDTOVASOn The Fly: Midday Wrap
Subscribe for More Information
10:25 EDTOVASBiologist 'highly troubled' by OvaScience study, Science Magazine reports
Excitement around OvaScience's recent pregnancy data is "far from universal," and one reproductive biologist said he is "highly troubled" that the company has already moved to human pregnancies, Science Magazine reports. No published animal studies with a control group have been done to test whether OvaScience's approach can improve fertility let alone whether it is safe for offspring, the magazine quotes John Eppig, a reproductive biologist at Jackson Laboratory in Bar Harbor, Maine, as saying. Shares of OvaScience are down 5%, or $2.08, to $36.10 in morning trading. Reference Link
10:15 EDTOVASOvaScience drops after Science journal discusses fertility treatments
Subscribe for More Information
March 29, 2015
13:37 EDTOVASOvaScience announces improved pregnancy rates with Augment fertility treatment
OvaScience announced that additional clinical experience of the company’s Augment treatment demonstrated improved pregnancy rates in women who had failed three to seven prior in vitro fertilization, IVF, cycles. These results were reported at the Society for Reproductive Investigation 62nd Annual Scientific Meeting being held in San Francisco, CA. The Augment treatment is not available in the United States.
March 27, 2015
16:23 EDTOVASOn The Fly: Closing Wrap
Stocks opened slightly higher but were unable to gather any upside momentum. They quickly crossed into negative territory but never really picked up speed to the downside. After the slightly better than expected consumer confidence reading, the averages moved back into positive ground where they spent most of the session hovering near the flat line. Near the close, comments by Fed Chair Janet Yellen that an interest rate hike "may be warranted later this year," lifted the averages into positive territory. ECONOMIC EVENTS: In the U.S., real GDP growth was steady at 2.2% in Q4, falling below consensus forecasts for 2.4% growth. GDP price index grew 0.1% on a linked quarter basis, matching expectations. U.S. consumer sentiment fell to 93.0 against consensus of 92.1. The current conditions index dipped to 105.0 from February's 106.9, while the consumer expectations index dropped to 85.3 from 88.0. COMPANY NEWS: Dow Chemical (DOW) and Olin (OLN) were up 3% and 14%, respectively, after announcing that Dow will separate much of its chlorine value chain and merge the entity with Olin in a $5B deal. Additionally, the companies announced a 20-year arrangement in which Dow will supply Olin with ethylene. Late in the session, the Wall Street Journal reported that Intel (INTC) was in talks to acquire Altera (ALTR), sending both stocks higher by 6% and 28%, respectively. MAJOR MOVERS: Among the notable gainers was Carnival (CCL), which rose over 6% after beating earnings expectations and raising FY15 revenue yield guidance. Also higher was BioMarin (BMRN), jumping 11% after speculation of a Shire (SHPG) takeover deal. Among the noteworthy losers was Southern Cooper (SCCO), which fell nearly 4% after the company cancelled its Tia Maria mining project. Also lower was OvaScience (OVAS), down 10% after Oppenheimer reported pushback from academics during the company's presentation of early Augment data. Opco cautioned, however, that criticism of non-trial data is "inevitable" and JMP Securities called the results encouraging. INDEXES: The Dow rose 34.43, or 0.19%, to 17,712.66, the Nasdaq gained 27.86, or 0.57%, to 4,891.22, and the S&P 500 added 4.87, or 0.24%, to 2,061.02.
12:36 EDTOVASOn The Fly: Midday Wrap
Subscribe for More Information
11:15 EDTOVASOppenheimer notes pushback from academics on AUGMENT data
Subscribe for More Information
08:39 EDTOVASOvaScience trial results encouraging, says JMP Securities
Subscribe for More Information
March 26, 2015
13:07 EDTOVASOvaSciencs says AUGMENT showed improved pregnancy rates in certain women
Subscribe for More Information
March 25, 2015
07:17 EDTOVASSociety for Reproductive Investigation to hold scientific meeting
62nd Annual Scientific Meeting: SRI 2015 is being held in San Francisco on March 25-28.
March 24, 2015
12:44 EDTOVASOn The Fly: Midday Wrap
Subscribe for More Information
11:03 EDTOVASOvaScience rises after scientific meeting abstracts posted
Subscribe for More Information
10:18 EDTOVASOvaScience jumps 14%, or $6.46, to $54.12
March 20, 2015
17:48 EDTOVASOvaScience could double from current levels, Barron's reports
Subscribe for More Information
17:16 EDTOVASLongwood Fund reports 6.5% stake in OvaScience
Subscribe for More Information
March 18, 2015
08:56 EDTOVASOvaScience bullish thesis on AUGMENT potential intact, says Credit Suisse
Subscribe for More Information
08:39 EDTOVASOvaScience abstracts encouraging, says JMP Securities
Subscribe for More Information
08:22 EDTOVASOvaScience decline based on misunderstanding, says Oppenheimer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use